Skip to main content
Ovation Science Inc. logo

Ovation Science Inc. — Investor Relations & Filings

Ticker · OVAT ISIN · CA69016D1087 LEI · 549300A1P7L8HTTQXY56 CSE Professional, scientific and technical activities
Open in API
Filings indexed 114 across all filing types
Latest filing 2022-08-26 Regulatory Filings
Country CA Canada
Listing CSE OVAT

About Ovation Science Inc.

https://ovationscience.com/

Ovation Science Inc. is a research and development company specializing in advanced topical and transdermal product formulations. The core technology is Invisicare®, a patented, high-performance drug delivery system engineered to enhance the penetration and efficacy of active ingredients, particularly cannabis and hemp-derived cannabinoids (CBD, THC, CBN, CBG). Ovation utilizes pharmaceutical protocols to develop these formulations. Its primary business model involves licensing the Invisicare® technology and proprietary formulations to international partners for manufacturing and market distribution. The company also distributes finished topical CBD products under proprietary brands, such as the Invibe® MD wellness line and ARLO CBD Beauty anti-aging line, all leveraging the unique delivery capabilities of Invisicare®.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO of Ovation Science Inc. regarding the interim financial report and interim MD&A for the period ended June 30, 2022. It is a Form 52-109FV2, a Venture Issuer Basic Certificate, which certifies the accuracy and fair presentation of the interim filings. The document does not contain the actual interim financial statements or substantive financial data but is an officer certification related to the interim report. According to the Certification Rule, such certifications should be classified as Regulatory Filings (RNS) rather than the interim report itself (IR). The document length is 3012 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2022-08-26 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements' for the three and six months ended June 30, 2022 and 2021. It contains detailed unaudited financial statements including statements of financial position, loss and comprehensive loss, changes in shareholders' equity, cash flows, and notes to the financial statements. The document explicitly states it is prepared in accordance with IFRS and IAS 34, which governs interim financial reporting. The presence of actual financial data and comprehensive financial analysis for a period shorter than a full fiscal year confirms this is an interim or quarterly report. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2022
2022-08-26 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 90% confidence The document is a notice regarding the upcoming Annual General Meeting (AGM) of Ovation Science Inc., providing details such as meeting type, record dates, meeting date, and voting securities information. It does not contain the AGM materials or presentations themselves, nor does it include financial data or voting results. The document is short (1149 characters) and serves as an announcement of the meeting and record dates. Therefore, it fits best under the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related notices about the AGM.
2022-08-25 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2, which is a certification of interim filings by a venture issuer's CEO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2021. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the interim filings but does not include them. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3008 characters), consistent with a certification letter rather than a full report.
2021-11-27 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of interim filings by the Chief Financial Officer of Ovation Science Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2021. The document is a certification letter and does not contain actual financial statements or substantive financial data. It explicitly states it is a certification under National Instrument 52-109 for venture issuers and does not include representations about internal controls. Given the document's nature as an officer certification related to interim filings, it should be classified as a Regulatory Filing (RNS) rather than an Interim Report (IR). The document length is short (3016 characters), consistent with a certification letter rather than a full report.
2021-11-27 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management Discussion & Analysis' (MD&A) for the three and nine months ended September 30, 2021 and 2020. It contains detailed narrative about the company's business, regulatory environment, and forward-looking statements. The MD&A is a management report explaining financial results, business trends, and outlook, typically accompanying interim or quarterly financial statements. The document references condensed consolidated interim financial statements prepared under IFRS, indicating it is part of an interim reporting package. The length (15,000 characters) and content indicate it is a substantive report, not a brief announcement or certification. Therefore, the document fits the category of an Interim / Quarterly Report (IR), which includes MD&A and financial data for a period shorter than a full fiscal year. 9M 2021
2021-11-27 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.